ライフサイエンスコーパス: RRT

1 RRT estimated that 10.4% of farmers killed badgers in th

2 There were 344 RRT calls during the study period.

3 rts from 584 inpatients involved in over 600 RRT events recorded in 2015.

4 r Mexican families when attempting to access RRT.

5 estimated the gap between needed and actual RRT, and projected needs to 2030.

6 poses clinical practice guidelines for acute RRT in Ebola virus disease.

7 Through technological advances, RRT can be offered to patients who are older and more fr

8 After RRT implementation, the mean monthly mortality rate decr

9 code rates outside of the ICU setting after RRT implementation at an academic children's hospital.

10 creatinine level or AKI-RRT, as well as AKI-RRT or in-hospital mortality (RRT/death).

11 re doubling of serum creatinine level or AKI-RRT, as well as AKI-RRT or in-hospital mortality (RRT/de

12 The deployment of an RRT led by physician assistants with specialized skills

13 Implementation of an RRT was associated with a statistically significant redu

14 Therapeutic interventions and RRT have limited influence on the outcome of AKI, and a

15 d not recover kidney function at 1 month and RRT at time of LT was the only factor associated with th

16 In-hospital mortality and RRT rates increased from 4.3% and 0%, respectively, for

17 The IPC-based RRT-PCR detected inhibitors in blood, kidney, lungs, spl

18 n people might have died prematurely because RRT could not be accessed.

19 From study entry to 18 months before RRT, GFR declined 7% faster among cases compared with co

20 ntrols (P<0.001) during the 18 months before RRT.

21 l of renal patients to a nephrologist before RRT is significantly associated with reduced access to r

22 or Medicaid beneficiaries in the year before RRT and who had been diagnosed with renal disease more t

23 or Medicaid beneficiaries in the year before RRT and who had been diagnosed with renal disease more t

24 d with renal disease more than 1 year before RRT.

25 sed with renal disease more than 1 yr before RRT.

26 is of children ages 2-19 years old beginning RRT from 1995 to 2011 using the US Renal Data System.

27 ion of viral RNA and subsequent detection by RRT-PCR.

28 mplification of the viral RNA and the IPC by RRT-PCR were monitored with two different fluorescent pr

29 stent with heart failure if fluid removal by RRT is delayed.

30 tion occurs before or after fluid removal by RRT.

31 patients aged >65 yr with new-onset chronic RRT who were New Jersey Medicare and/or Medicaid benefic

32 ohort of all patients with new-onset chronic RRT who were New Jersey Medicare and/or Medicaid benefic

33 y post-OLTx, n=17; and group III: continuous RRT post-OLTx, n=70.

34 ammonia levels, 61 (18%) were on continuous RRT (CRRT), 59 (17%) were on intermittent RRT (IRRT), an

35 ntermittent hemodialysis (IHD) or continuous RRT (CRRT), respectively.

36 mong critically ill patients with AKI, early RRT compared with delayed initiation of RRT reduced mort

37 dependently predictive of the need for early RRT and in combination formed a parsimonious model that

38 The need for early RRT was strongly associated with death before hospital d

39 rces than patients who did not require early RRT, spending more time in intensive care (15 +/- 13 d v

40 ctions of which patients would require early RRT.

41 Twenty-eight patients required early RRT (RRT initiated within 1 wk of transplant); 23 for co

42 Patients requiring early RRT consumed more healthcare resources than patients who

43 llow-up of 4.9 years, chronic renal failure, RRT, all fractures, hip fractures, and vertebral fractur

44 al (< or = 90 days vs. >90 days before first RRT) and socioeconomic status (lower socioeconomic statu

45 tinuous veno-venous hemodialysis (CVVHD) for RRT has been reported in three series of OLTX patients w

46 hospital or ICU length of stay, or need for RRT after hospital discharge.

47 The need for RRT has increased along with waiting time in OLTX patien

48 point of all-cause mortality or the need for RRT in a secondary analysis of a prospective observation

49 e independently associated with the need for RRT in the early posttransplant period.

50 acute renal failure and reduce the need for RRT postoperatively are needed.

51 Patients developing the need for RRT postoperatively have an increased 90-day mortality a

52 nts at high risk for developing the need for RRT postoperatively.

53 for prediction of progressive AKI, need for RRT, and inpatient mortality.

54 urs or >/=50% within 5 days, or the need for RRT.

55 e and urine output domains with the risk for RRT and likelihood of renal recovery and survival using

56 tes in 2001-2002, and mortality hazards from RRT initiation, relative to hazards in 2001-2002.

57 The matrix gene RRT-PCR assay has a detection limit of 10 fg or approxim

58 susceptible to TCV because of a second gene, RRT, that regulates resistance to TCV.

59 n the early group than in the delayed group (RRT: 9 days [Q1, Q3: 4, 44] in the early group vs 25 day

60 In the buffered crystalloid group, RRT was used in 38 of 1152 patients (3.3%) compared with

61 In all CHA(2)DS(2)-VASc risk groups, RRT was independently associated with a higher risk of s

62 nous application of SA confers resistance in RRT-containing plants by increasing HRT transcript level

63 Although the future incident RRT population will be determined in part by population

64 The reduction in incident RRT, not death, drove this effect on the composite among

65 s with CKD experience less death or incident RRT when treated with off-pump compared with on-pump CAB

66 ted for most of the increase in the incident RRT population in all age groups during this time period

67 Similarly, the incident RRT population increased substantially in all age groups

68 ased model designed to permit individualized RRT prescription to ARF patients was developed.

69 T-free when the corresponding case initiated RRT (controls).

70 Children (n=125) who initiated RRT (cases) during follow-up were individually matched b

71 us RRT (CRRT), 59 (17%) were on intermittent RRT (IRRT), and 220 (65%) received no RRT for the first

72 eated with reduced-dose cranial irradiation (RRT) of 23.4 Gy.

73 is, the strongest factor predicting lessened RRT and NRM was nonmyeloablative conditioning, whereas h

74 clusion, nonmyeloablative regimens had lower RRT and NRM and could be considered for comparative stud

75 as well as AKI-RRT or in-hospital mortality (RRT/death).

76 rted all-cause and cardiovascular mortality, RRT, kidney function, BP, and adverse events.

77 t differences in kidney function, mortality, RRT, cardiovascular events, or pulmonary edema.

78 tly no significant differences in mortality, RRT, or cardiovascular events but heterogeneous effects

79 g ESRD due to multiple myeloma necessitating RRT in the United States, we evaluated temporal trends b

80 We estimated the number of patients needing RRT to be between 4.902 million (95% CI 4.438-5.431 mill

81 eligible patients, 22 patients (13 SRT, nine RRT) participated in a battery of tests that included in

82 by 38%, 23%, and 19% with CRRT, IRRT, and no RRT, respectively.

83 studied, which were divided into group I: no RRT, n=637; group II: hemodialysis only post-OLTx, n=17;

84 ittent RRT (IRRT), and 220 (65%) received no RRT for the first 2 days.

85 Comparing to no RRT use, whereas ammonia reduction with CRRT was signifi

86 less than Y/RRT less than O/SRT less than O/RRT.

87 es, and contacted national experts to obtain RRT prevalence data.

88 id, serum, or tracheal swabs The accuracy of RRT-PCR test results with the lyophilized beads was test

89 is to prescribe generally similar amounts of RRT to ARF patients essentially without regard for the a

90 of AKI and prompt, judicious application of RRT may also improve outcomes.

91 igher rate of death during the first 90 d of RRT compared with HD patients (hazard ratio [HR], 1.16;

92 l for the first known successful delivery of RRT with subsequent renal recovery in a patient with Ebo

93 Duration of RRT and length of hospital stay were significantly short

94 Second, we studied the effect of RRT on ammonia for the first 3 days post study admission

95 utation, overcame the suppressive effects of RRT and enhanced resistance to TCV, provided the HRT all

96 This study provides the first estimate of RRT incidence in the Turkish-Cypriot population, describ

97 These data suggest the incidence of RRT from multiple myeloma in the United States has decre

98 The incidence of RRT is higher than other countries reporting to the Euro

99 ); main secondary outcomes were incidence of RRT use and in-hospital mortality.

100 [39.3%]) compared with delayed initiation of RRT (65 of 119 patients [54.7%]; hazard ratio [HR], 0.66

101 ts in the Early Versus Delayed Initiation of RRT in Critically Ill Patients with AKI (ELAIN) Trial fr

102 Whether earlier initiation of RRT in critically ill patients with AKI can improve outc

103 In conclusion, early initiation of RRT in these critically ill patients with AKI significan

104 arly RRT compared with delayed initiation of RRT reduced mortality over the first 90 days.

105 Early initiation of RRT significantly reduced 90-day mortality (44 of 112 pa

106 t vascular access, and delayed initiation of RRT.

107 AKI or no initiation; n = 119) initiation of RRT.

108 ucation and uninformed choice of modality of RRT, delayed placement of a permanent vascular access, a

109 ce (white/black/other), and year of onset of RRT (+/-1 year) but had not received a transplant on ind

110 Using number of days from onset of RRT to transplantation as the index date for cases, we s

111 ty and should be used as an integral part of RRT programmes.

112 teinuria was also a significant predictor of RRT after CF-LVAD implantation.

113 /=0.55 mg/mg) were significant predictors of RRT after CF-LVAD support.

114 son regression to estimate the prevalence of RRT for countries without reported data.

115 The age-adjusted prevalence of RRT in Turkish-Cypriots was 1543 pmp on 01/01/2011.

116 nt of stage 3 AKI (n=25 [32.5%]), receipt of RRT (n=11 [14.2%]), or inpatient mortality (n=16 [20.7%]

117 ed to 0.90+/-0.06 and the AUC for receipt of RRT improved to 0.91+/-0.08.

118 t increased risk for mortality or receipt of RRT over the next 9 months.

119 , recovery of renal function, requirement of RRT after day 90, duration of renal support, and intensi

120 was no significant effect on requirement of RRT after day 90, organ dysfunction, and length of ICU s

121 ion rate and proteinuria had highest risk of RRT (63.6%) compared with those with either low estimate

122 ccurate clinical prediction of the timing of RRT and adequate patient preparation.

123 -term outcomes associated with the timing of RRT initiation in such patients.

124 etermine the effect of necessity and type of RRT on patient survival after OLTX.

125 RRT, when they received RRT, and the type of RRT.

126 .52 [95% CI, 0.37-0.75]; P <.001) and use of RRT (odds ratio, 0.52 [95% CI, 0.33-0.81]; P = .004).

127 Use of RRT increased from 8.29% in period I to 12.45% in period

128 Worldwide use of RRT is projected to more than double to 5.439 million (3

129 6.4%-10%; n = 65) (P <.001), and the use of RRT was 10% (95% CI, 8.1%-12%; n = 78) vs 6.3% (95% CI,

130 e composite of in-hospital mortality, use of RRT, and persistent elevated serum creatinine >/=200% fr

131 y, we examined severe AKI, defined as use of RRT, as a primary outcome.

132 decrease in the incidence of AKI and use of RRT.

133 per 100 person-years in the first 3 years of RRT, respectively, compared with 32.3, 20.6, and 21.3 in

134 The data demonstrate that dependency on RRT in the first week after orthotopic liver transplanta

135 urvival of patients with multiple myeloma on RRT has improved.

136 e applied back to individual patients not on RRT (including patients prescribed intermittent dialysis

137 e applied back to individual patients not on RRT (including patients prescribed intermittent dialysis

138 and, eventually, outcomes among patients on RRT.

139 rvival of 73.6% in those patients started on RRT preoperatively, P=0.03.

140 Six patients were on RRT at time of biopsy.

141 in colistin clearance when patients were on RRT was determined from the population analysis and guid

142 e that short- and long-term risk of death or RRT is greatest when patients meet both the serum creati

143 P7] levels>0.3 were associated with death or RRT only in subjects who developed AKI (compared with le

144 uction in the composite in-hospital death or RRT, with patients having lower preoperative renal funct

145 transcription (RT)-PCR and real-time RT-PCR (RRT-PCR).

146 A real-time reverse transcriptase PCR (RRT-PCR) assay based on the avian influenza virus matrix

147 A real-time reverse-transcription PCR (RRT-PCR) was developed to detect avian paramyxovirus 1 (

148 the only biomarker to significantly predict RRT (0.86+/-0.08; P=0.001).

149 ltration rate and proteinuria are predictors RRT after CF-LVAD implantation and should be routinely a

150 In period I, patients receiving preoperative RRT had a 90-day mortality (0%) and a 1-year survival (8

151 Providing RRT in Ebola virus disease is complex and requires metic

152 tients (90.8%) in the delayed group received RRT.

153 In 2010, 2.618 million people received RRT worldwide.

154 or not they received RRT, when they received RRT, and the type of RRT.

155 oups defined on whether or not they received RRT, when they received RRT, and the type of RRT.

156 A total of 15 of 20 patients who received RRT and 111 of 121 who did not were correctly classified

157 -hospital mortality in patients who received RRT services.

158 non-end-stage CKD and 1,728 (1.1%) receiving RRT.

159 t of an algorithm for patients not receiving RRT was based upon the relationship between the dose of

160 907 million people needing but not receiving RRT; conservative model) and Africa (432,000 people; con

161 D patients are seen within 90 d of receiving RRT.

162 In patients receiving RRT with CHA(2)DS(2)-VASc score >/=2, warfarin was assoc

163 For patients receiving RRT, target attainment rates were >80% with the proposed

164 The large number of people receiving RRT and the substantial number without access to it show

165 diagnosis with children (n=125) who remained RRT-free when the corresponding case initiated RRT (cont

166 l timing of initiation of renal replacement (RRT) therapy has been debated.

167 Forty-four patients (11.6%) required RRT during a median follow-up of 9.9 months.

168 entical to those patients who never required RRT (1.7% and 90.6%).

169 In patients that required RRT 1-year mortality was 28.2% (log-rank test P = 0.001)

170 enal failure postoperatively, which required RRT, regardless of therapy, had a 1-year survival of onl

171 In multivariable analysis only AKI requiring RRT was an independent predictor of 1-year mortality (ha

172 h 6.9% and 88.6% in patients never requiring RRT.

173 e 40 years of age and others never requiring RRT.

174 In period II, patients requiring RRT had a 90-day mortality of 39.7% and a 1-year actuari

175 Patients requiring RRT had significantly worse renal function, lower hemogl

176 cute renal failure postoperatively requiring RRT, however, had a 90-day mortality of 28.6% and a 1-ye

177 Twenty-eight patients required early RRT (RRT initiated within 1 wk of transplant); 23 for control

178 ng motifs related to the sequence RRTGXPPXL (RRT motif).

179 y and specificity of the H7- and H5-specific RRT-PCR were similar to those of VI and HI.

180 Influenza virus-specific RRT-PCR results correlated with VI results for 89% of th

181 le Ebola virus genetic material in the spent RRT effluent waste.

182 and non-Hispanic white children who started RRT between 1995 and 2011 and were followed through 2012

183 revalence of obesity among children starting RRT may impede kidney transplantation, especially from l

184 Introduction of a rapid response team (RRT) has been shown to decrease mortality and cardiopulm

185 system that included a rapid response team (RRT) led by physician assistants with specialized critic

186 l emergency team (MET), rapid response team (RRT), or critical care outreach (CCO).

187 e techniques (Randomized Response Technique (RRT); projective questioning (PQ); brief implicit associ

188 ine doubling and/or ESRD requiring long-term RRT.

189 uggest the presence of a second gene, termed RRT, that regulates resistance to TCV.

190 It is currently recommended that RRT be instituted once the GFR falls below 10.5 ml/min p

191 The RRT included a pediatric ICU-trained fellow or attending

192 The RRT-PCR assay utilizes a one-step RT-PCR protocol and fl

193 The RRT-PCR test was further simplified with the use of lyop

194 The RRT-PCR test was used to examine clinical samples from c

195 The RRT-PCR with the bead reagents was more sensitive than t

196 ositive correlation was obtained between the RRT-PCR results and virus isolation for NDV from clinica

197 conclude that SA enhances resistance in the RRT background by upregulating HRT expression.

198 tation often occurred within two days of the RRT event and many patients (46.8%) died within one day

199 82% and decreased to 2.35% by the end of the RRT year.

200 , indicating a high level of accuracy of the RRT-PCR assay.

201 There was 97 to 100% agreement of the RRT-PCR test results with VI for tracheal swabs and 81%

202 death or incident renal replacement therapy (RRT) across strata of preoperative renal function.

203 P=0.03), whereas renal replacement therapy (RRT) and Aspergillus colonization were significant predi

204 ced in supporting Renal Replacement Therapy (RRT) and providing equitable patient care, despite recen

205 l before onset of renal replacement therapy (RRT) and the likelihood of receiving a renal transplant.

206 worldwide use of renal replacement therapy (RRT) are expected to rise sharply in the next decade.

207 mmonly started on renal replacement therapy (RRT) as soon as (or, in some centers, before) the usual

208 dy endpoints were renal replacement therapy (RRT) at 1 month and the need for kidney transplantation

209 the initiation of renal replacement therapy (RRT) at an estimated GFR >/=10 ml/min per 1.73 m(2).

210 the first year of renal replacement therapy (RRT) between elderly patients starting treatment on hemo

211 ho do not receive renal replacement therapy (RRT) develop signs and symptoms of heart failure, includ

212 The need for renal replacement therapy (RRT) either before or after orthotopic liver transplant

213 of initiation of renal replacement therapy (RRT) for severe acute kidney injury (AKI) but without li

214 failure requiring renal replacement therapy (RRT) has detrimental effects on quality of life and surv

215 for postoperative renal replacement therapy (RRT) in patients undergoing liver transplantation.

216 ll those starting renal replacement therapy (RRT) in this population.

217 ted the effect of renal replacement therapy (RRT) on serum ammonia level and outcomes in ALF.

218 Renal replacement therapy (RRT) requirements for critically ill patients with acute

219 medical care and renal replacement therapy (RRT) the morbidity, mortality and cost of postoperative

220 with preoperative renal replacement therapy (RRT) were excluded.

221 hed AKI requiring renal replacement therapy (RRT) were excluded.

222 min; 29 receiving renal replacement therapy (RRT)) were subjected to population pharmacokinetic analy

223 min; 29 receiving renal replacement therapy (RRT)) were subjected to population pharmacokinetic analy

224 kidney function, renal replacement therapy (RRT), and death.

225 e preparation for renal replacement therapy (RRT), and timely initiation of dialysis.

226 uded the need for renal replacement therapy (RRT), length of stay in ICU and hospital, and survival.

227 eir first year of renal replacement therapy (RRT).

228 he cornerstone of renal replacement therapy (RRT).

229 nts (5%) required renal replacement therapy (RRT).

230 renal failure and renal replacement therapy [RRT]) and bone events (incident hip, vertebral, and all

231 e.g., patients on renal replacement therapy [RRT]) was estimated using Cox regression analyses.

232 3) from meeting full eligibility criteria to RRT initiation was significantly shorter in the early gr

233 n named as regulators of rDNA transcription (RRT).

234 patients) were managed conservatively until RRT was judged necessary by their chosen dialysis or tra

235 validation, this methodology may be a useful RRT prescription tool for critically ill ARF patients.

236 ts were stratified by treatment group (SRT v RRT) and into younger (Y) and older (O) groups by the me

237 armers' badger killing behavior reported via RRT.

238 Primary end point was RRT initiation or >50% reduction in initial eGFR.

239 To determine whether RRT can safely be deferred beyond this point, adults wit

240 was to identify risk factors associated with RRT after CF-LVAD implantation.

241 th ESRD due to multiple myeloma treated with RRT (n=12,703).

242 of non-Hispanic black children treated with RRT.

243 on were analyzed in patients with or without RRT after CF-LVAD implantation.

244 es in the following order: Y/SRT less than Y/RRT less than O/SRT less than O/RRT.